Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis

Coronary heart disease (CHD) is the leading cause of mortality worldwide. Previous studies have suggested that cilostazol-based triple antiplatelet therapy (TAT) may be more effective than conventional dual antiplatelet therapy (DAT) at improving the clinical outcomes of patients with CHD undergoing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: ZHOU, HONG, FENG, XIAO-LING, ZHANG, HONG-YING, XU, FEI-FEI, ZHU, JIE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797250/
https://ncbi.nlm.nih.gov/pubmed/24137311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2013.1238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados